A role for plasminogen activator inhibitor-1 in obesity: from pie to PAI? - PubMed (original) (raw)
Review
A role for plasminogen activator inhibitor-1 in obesity: from pie to PAI?
Marcelo L G Correia et al. Arterioscler Thromb Vasc Biol. 2006 Oct.
No abstract available
Comment on
- Modulation of adipose tissue development by pharmacological inhibition of PAI-1.
Crandall DL, Quinet EM, El Ayachi S, Hreha AL, Leik CE, Savio DA, Juhan-Vague I, Alessi MC. Crandall DL, et al. Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2209-15. doi: 10.1161/01.ATV.0000235605.51400.9d. Epub 2006 Jul 6. Arterioscler Thromb Vasc Biol. 2006. PMID: 16825598
Similar articles
- Modulation of adipose tissue development by pharmacological inhibition of PAI-1.
Crandall DL, Quinet EM, El Ayachi S, Hreha AL, Leik CE, Savio DA, Juhan-Vague I, Alessi MC. Crandall DL, et al. Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2209-15. doi: 10.1161/01.ATV.0000235605.51400.9d. Epub 2006 Jul 6. Arterioscler Thromb Vasc Biol. 2006. PMID: 16825598 - Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis.
Hennan JK, Elokdah H, Leal M, Ji A, Friedrichs GS, Morgan GA, Swillo RE, Antrilli TM, Hreha A, Crandall DL. Hennan JK, et al. J Pharmacol Exp Ther. 2005 Aug;314(2):710-6. doi: 10.1124/jpet.105.084129. Epub 2005 Apr 28. J Pharmacol Exp Ther. 2005. PMID: 15860572 - Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization.
Elokdah H, Abou-Gharbia M, Hennan JK, McFarlane G, Mugford CP, Krishnamurthy G, Crandall DL. Elokdah H, et al. J Med Chem. 2004 Jul 1;47(14):3491-4. doi: 10.1021/jm049766q. J Med Chem. 2004. PMID: 15214776 - Plasminogen activator inhibitor-1, adipose tissue and insulin resistance.
Alessi MC, Poggi M, Juhan-Vague I. Alessi MC, et al. Curr Opin Lipidol. 2007 Jun;18(3):240-5. doi: 10.1097/MOL.0b013e32814e6d29. Curr Opin Lipidol. 2007. PMID: 17495595 Review.
Cited by
- Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus.
Eschler DC, Kulina G, Garcia-Ocana A, Li J, Kraus T, Levy CJ. Eschler DC, et al. Biores Open Access. 2018 Aug 1;7(1):123-130. doi: 10.1089/biores.2018.0013. eCollection 2018. Biores Open Access. 2018. PMID: 30147996 Free PMC article. - A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease.
Morrow GB, Whyte CS, Mutch NJ. Morrow GB, et al. Front Cardiovasc Med. 2021 Apr 16;8:653655. doi: 10.3389/fcvm.2021.653655. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33937363 Free PMC article. Review. - Biochemistry of adipose tissue: an endocrine organ.
Coelho M, Oliveira T, Fernandes R. Coelho M, et al. Arch Med Sci. 2013 Apr 20;9(2):191-200. doi: 10.5114/aoms.2013.33181. Epub 2013 Feb 10. Arch Med Sci. 2013. PMID: 23671428 Free PMC article. - Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome.
Khoukaz HB, Ji Y, Braet DJ, Vadali M, Abdelhamid AA, Emal CD, Lawrence DA, Fay WP. Khoukaz HB, et al. Arterioscler Thromb Vasc Biol. 2020 Jun;40(6):1479-1490. doi: 10.1161/ATVBAHA.119.313775. Epub 2020 Apr 9. Arterioscler Thromb Vasc Biol. 2020. PMID: 32268785 Free PMC article. - Exploring the Therapeutic Potential of Apigenin in Obesity-Associated Fibrinolytic Dysfunction: Insights From an Animal Study.
Qadi HH, Bendary MA, Almaghrabi SY, Zaher MAF, Karami MM, Alsehli AM, Babateen O, Arbaeen AF, Burzangi AS, Bazuhair MA. Qadi HH, et al. Cureus. 2023 Jun 25;15(6):e40943. doi: 10.7759/cureus.40943. eCollection 2023 Jun. Cureus. 2023. PMID: 37503477 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical